Clinical Implication of Blood Levels of B-Type Natriuretic Peptide in Pediatric Patients on Mechanical Circulatory Support

Annals of Thoracic Surgery

Volumn 81, Issue 6, 2006, Pages 2267-2272

  Huang, Shu Chien ^a   Wu, En Ting ^a   Ko, Wen Je ^a   Lai, Ling Ping ^a   Hsu, Juin ^a   Chang, Chung I ^a   Chiu, Ing Sh ^a   Wang, Shoei Shen ^a   Wu, Mei Hwan ^a   Lin, Fang Yue ^a   Chen, Yih Sharng ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; HEART TRANSPLANTATION; HUMAN; INFANT; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; CARDIAC OUTPUT, LOW; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART ARREST; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE; MALE; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33646842287     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.12.061     Document Type: Article

References (27)

1. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
2. Goetze J.P., Christoffersen C., Perko M., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 17 (2003) 1105-1107
3. Maisel A. B-type natriuretic peptide levels. a potential novel "white count" for congestive heart failure. J Card Fail 7 (2001) 183-193
4. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
5. Mega J.L., Morrow D.A., De Lemos J.A., et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction. an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 44 (2004) 335-339
6. Sodian R., Loebe M., Schmitt C., et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 38 (2001) 1942-1949
7. Thompson L.O., Skrabal C.A., Loebe M., et al. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. J Surg Res 123 (2005) 25-32
8. Duncan B.W. Mechanical circulatory support for infants and children with cardiac disease. Ann Thorac Surg 73 (2002) 1670-1677
9. Jacobs J.P., Ojito J.W., McConaghey T.W., et al. Rapid cardiopulmonary support for children with complex congenital heart disease. Ann Thorac Surg 70 (2000) 742-749
10. Huang S.C., Yu H.Y., Ko W.J., et al. Pressure criterion for placement of distal perfusion catheter to prevent limb ischemia during adult extracorporeal life support. J Thorac Cardiovasc Surg 128 (2004) 776-777
11. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
12. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106 (2002) 416-422
13. Cohen S., Springer C., Avital A., et al. Amino-terminal pro-brain-type natriuretic peptide. heart or lung disease in pediatric respiratory distress?. Pediatrics 115 (2005) 1347-1350
14. Law Y.M., Keller B.B., Feingold B.M., et al. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 95 (2005) 474-478
15. Kuhn M., Voss M., Mitko D., et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res 64 (2004) 308-314
16. Berdjis F., Takahashi M., and Lewis A.B. Left ventricular performance in neonates on extracorporeal membrane oxygenation. Pediatr Cardiol 13 (1992) 141-145
17. Martin G.R., Chauvin L., and Short B.L. Effects of hydralazine on cardiac performance in infants receiving extracorporeal membrane oxygenation. J Pediatr 118 (1991) 944-948
18. Chello M., Mastroroberto P., Perticone F., et al. Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass. Eur J Cardiothorac Surg 20 (2001) 140-146
19. Conrad S.A., Rycus P.T., and Dalton H. Extracorporeal Life Support Registry Report 2004. ASAIO J 51 (2005) 4-10
20. Di Russo G.B., and Martin G.R. Extracorporeal membrane oxygenation for cardiac disease. no longer a mistaken diagnosis. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 8 (2005) 34-40
21. Kolovos N.S., Bratton S.L., Moler F.W., et al. Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery. Ann Thorac Surg 76 (2003) 1435-1441
22. Morris M.C., Ittenbach R.F., Godinez R.I., et al. Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation. Crit Care Med 32 (2004) 1061-1069
23. Cheung P.Y., Etches P.C., Weardon M., et al. Use of plasma lactate to predict early mortality and adverse outcome after neonatal extracorporeal membrane oxygenation. a prospective cohort in early childhood. Crit Care Med 30 (2002) 2135-2139
24. Troughton R.W., Frampton C.M., Yandle T.G., et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
25. Cheng V., Kazanagra R., Garcia A., et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure. a pilot study. J Am Coll Cardiol 37 (2001) 386-391
26. Gackowski A., Isnard R., Golmard J.L., et al. Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J 25 (2004) 1788-1796
27. Beishuizen A., Hartemink K.J., Vermes I., et al. Circulating cardiovascular markers and mediators in acute illness. an update. Clin Chim Acta 354 (2005) 21-34